191 related articles for article (PubMed ID: 19024097)
21. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.
Kelbaek H; Kløvgaard L; Helqvist S; Lassen JF; Krusell LR; Engstrøm T; Bøtker HE; Jørgensen E; Saunamäki K; Aljabbari S; Thayssen P; Galløe A; Jensen GV; Thuesen L
J Am Coll Cardiol; 2008 May; 51(21):2011-6. PubMed ID: 18498953
[TBL] [Abstract][Full Text] [Related]
22. Six-month clinical outcomes of Firebird 2TM sirolimus-eluting stent implantation in real-world patients with coronary artery diseases.
Ge JB; Zhang F; Qian JY; Ge L; Liu XB; Zhou J
Chin Med J (Engl); 2011 Mar; 124(6):831-5. PubMed ID: 21518588
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.
Han YL; Zhang J; Li Y; Wang SL; Jing QM; Yi XH; Ma YY; Luan B; Wang G; Wang B
Chin Med J (Engl); 2009 Mar; 122(6):643-7. PubMed ID: 19323927
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
[TBL] [Abstract][Full Text] [Related]
25. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.
Minutello RM; Bhagan S; Sharma A; Slotwiner AJ; Feldman DN; Cuomo LJ; Wong SC
J Interv Cardiol; 2007 Dec; 20(6):458-65. PubMed ID: 18042050
[TBL] [Abstract][Full Text] [Related]
26. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
Qasim A; Cosgrave J; Latib A; Colombo A
Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
[TBL] [Abstract][Full Text] [Related]
28. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
Weisz G; Moses JW; Teirstein PS; Holmes DR; Raizner AE; Satler LF; Mishkel G; Wilensky RL; Wang P; Kuntz RE; Popma JJ; Leon MB
Am J Cardiol; 2007 Apr; 99(8):1044-50. PubMed ID: 17437725
[TBL] [Abstract][Full Text] [Related]
29. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
[TBL] [Abstract][Full Text] [Related]
30. Long-term safety and efficacy of sirolimus-eluting stents in Japanese patients: a single-center cohort study.
Nakamura M; Yamashita T; Yajima J; Oikawa Y; Ogasawara K; Kirigaya H; Nagashima K; Sawada H; Aizawa T
J Invasive Cardiol; 2009 Oct; 21(10):526-31. PubMed ID: 19805840
[TBL] [Abstract][Full Text] [Related]
31. Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.
Gershlick A; Kandzari DE; Leon MB; Wijns W; Meredith IT; Fajadet J; Popma JJ; Fitzgerald PJ; Kuntz RE;
Am J Cardiol; 2007 Oct; 100(8B):45M-55M. PubMed ID: 17950832
[TBL] [Abstract][Full Text] [Related]
32. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up of crush versus no crush technique for coronary artery bifurcation lesions.
Gao Z; Yang YJ; Xu B; Chen JL; Qiao SB; Li JJ; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; Liu HB; Dai J; Gao RL
Chin Med J (Engl); 2009 Mar; 122(6):627-31. PubMed ID: 19323924
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
[TBL] [Abstract][Full Text] [Related]
35. Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry).
Planer D; Beyar R; Almagor Y; Banai S; Guetta V; Miller H; Kornowski R; Brandes S; Krakover R; Solomon M; Lotan C
Am J Cardiol; 2008 Apr; 101(7):953-9. PubMed ID: 18359314
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial.
Moses JW; Nikolsky E; Mehran R; Cambier PA; Bachinsky WB; Leya F; Kuntz RE; Popma JJ; Schleckser P; Wang H; Cohen SA; Leon MB;
Am J Cardiol; 2006 Dec; 98(11):1455-60. PubMed ID: 17126649
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis.
Mahmud E; Bromberg-Marin G; Palakodeti V; Ang L; Creanga D; Demaria AN
J Am Coll Cardiol; 2008 Jun; 51(25):2385-95. PubMed ID: 18565394
[TBL] [Abstract][Full Text] [Related]
38. Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry.
Costa JR; Sousa A; Moreira AC; Costa RA; Maldonado G; Cano MN; Egito ET; Romano ER; Barbosa M; Pavanello R; Jardim C; Cury A; Berwanger O; Sousa JE
J Invasive Cardiol; 2008 Aug; 20(8):404-10. PubMed ID: 18688065
[TBL] [Abstract][Full Text] [Related]
39. Crush stenting in treating coronary bifurcate lesions: paclitaxel eluting stents versus sirolimus eluting stents.
Chen SL; Zhang JJ; Ye F; Chen YD; Zhu ZS; Lin S; Tian NL; Liu ZZ; Fang WY; Sun XW; Hu DY; Kwan TW
Chin Med J (Engl); 2008 Mar; 121(6):528-33. PubMed ID: 18364140
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
